Show simple item record

dc.contributor.authorGill, DM
dc.contributor.authorIveson, M
dc.contributor.authorCollins, I
dc.contributor.authorJones, AM
dc.date.accessioned2018-01-24T12:49:58Z
dc.date.issued2018-01-17
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424308900010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9
dc.identifier.citationTETRAHEDRON LETTERS, 2018, 59 (3), pp. 238 - 242 (5)
dc.identifier.issn0040-4039
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1014
dc.identifier.doi10.1016/j.tetlet.2017.12.017
dc.format.extent238 - 242 (5)
dc.languageeng
dc.language.isoeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD
dc.rights.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
dc.subjectScience & Technology
dc.subjectPhysical Sciences
dc.subjectChemistry, Organic
dc.subjectChemistry
dc.subjectMitsunobu
dc.subjectCyclodehydration
dc.subjectNucleophilic aromatic substitution
dc.subjectIntramolecular
dc.subjectCyclisation
dc.subjectINHIBITORS
dc.subjectCYCLODEHYDRATION
dc.subjectHSP70
dc.subjectPHASE
dc.titleA Mitsunobu reaction to functionalized cyclic and bicyclic N-arylamines
dc.typeJournal Article
dcterms.dateAccepted2017-12-04
rioxxterms.versionofrecord10.1016/j.tetlet.2017.12.017
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
rioxxterms.licenseref.startdate2018-01-17
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfTETRAHEDRON LETTERS
pubs.issue3
pubs.notes24 months
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 2
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicinal Chemistry 2
pubs.publication-statusPublished
pubs.volume59
pubs.embargo.terms24 months
icr.researchteamMedicinal Chemistry 2en_US
dc.contributor.icrauthorCollins, Ianen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record